16小时的禁食优化了小鼠和人类的癌症免疫疗法
Sheng Chen1, Tianyi Hu2, Kaixiang Zhu3
1Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310017, P.R. China; Cancer Center, Zhejiang University, Hangzhou 310058, P.R. China.
Cell metabolism
|February 20, 2026
概括
短暂的16小时禁食通过改变瘤代谢来增强癌症免疫疗法. 这种短期禁食可以促进CD8+T细胞的功能,改善小鼠和人类的抗瘤能力.
科学领域:
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
- 代谢调节 代谢调节 代谢调节
背景情况:
- 饮食干预措施在癌症治疗中表现有前途,但往往涉及到长期的,耐受性较差的治疗方案.
- 暂时的营养缺乏对瘤细胞和瘤微环境 (TME) 内的免疫细胞之间的代谢相互作用的影响尚不清楚.
研究的目的:
- 为了研究短暂的16小时禁食对免疫治疗疗效的影响.
- 阐明短期禁食增强TME内抗瘤免疫力的机制.
主要方法:
- 对接受免疫治疗的小鼠和人类患者进行了16小时的禁食治疗.
- 进行了代谢和免疫学分析,以评估TME的变化,包括营养偏好,异黄素水平和CD8+T细胞功能.
主要成果:
- 短期禁食增强了小鼠和人类的免疫疗法疗效.
- 禁食诱导了异黄素的内积累,该异黄素重新配置了CD8+T细胞表观遗传程序和脂重塑.
- 在患者中,短期禁食促进了CD8+ T细胞克隆扩张和细胞毒性程序.
结论:
- 简短的16小时禁食是临床上可行的,耐受性良好的饮食干预措施,可以增强免疫疗法.
- 禁食会在TME内抵制营养竞争,创造一个代谢窗口来增强抗瘤免疫反应.
- 这种饮食策略提供了一个可操作的方法来加强现有的免疫疗法方案.
相关概念视频
Mouse Models of Cancer Study
6.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K


